HB 1440 — Maryland

Maryland Medical Assistance Program and Health Insurance - Coverage and Utilization Review - Drugs Reviewed by the Prescription Drug Affordability Board

Prohibiting a managed care organization and certain insurers, nonprofit health service plans, and health maintenance organizations from requiring a prior authorization or step therapy or fail-first protocol under certain circumstances for prescription drugs that have been reviewed by the Prescription Drug Affordability Board; etc.

Latest action: Withdrawn by Sponsor · Mar 13, 2026

WithdrawnClassifications and DesignationsCommittees and CommissionsDrugsHealth - InsuranceHealth InsuranceHealth Maintenance OrganizationsManaged Care OrganizationsMedical AssistanceMedical TreatmentsNonprofit OrganizationsPrices

Synopsis written by the legislature's own staff, as published on the official bill page. Status label is derived from the recorded actions. The full text below is the record.

Committees: Health (House of Delegates)

Updated Mar 17, 2026

Timeline

First Reading Health
Feb 13, 2026 · House of Delegates
Hearing 3/13 at 1:00 p.m.
Feb 13, 2026 · House of Delegates
Hearing canceled
Mar 11, 2026 · House of Delegates
Withdrawn by Sponsor
Mar 13, 2026 · House of Delegates

Sponsored by Teresa Woorman, Aaron Kaufman, Martinez

No recorded floor votes yet.

Fiscal and Policy Note — official analysis by legislative staff (PDF) Bill text (First reading) — Maryland General Assembly (PDF) Official record — Maryland General Assembly bill page

Official records. Maryland legislators, bills and roll-call votes from the Maryland General Assembly, imported through Open States on Oct 27, 2026 (partial import — not yet the full session). Accuracy review against the official site is still under way. Campaign-finance records for Maryland are not imported yet.